Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Cetuximab in Head and Neck Cancer Patients [Phase 2]
A Phase 2 clinical trial update for cetuximab in head and neck squamous cell carcinoma has been completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy [Phase 3]
A Phase 3 clinical trial evaluating nivolumab alone or with ipilimumab vs standard follow-up as immunotherapy for surgically resectable head…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: CONNECTing Head and Neck Caregivers to Supportive Care Resources [NA]
A completed clinical trial study update focusing on connecting head and neck cancer caregivers to supportive care resources; results posted …
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) [Phase 1, Phase 2]
Phase 1/2 study evaluating Epacadostat in combination with Nivolumab in select advanced cancers; results have been posted following completi…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Clinical Study On Acute Radiotherapy-Induced Oral Mucositis In Patients With Locally Advanced Head And Neck Tumors [Phase 3]
Phase 3 clinical trial assessing treatment for acute radiotherapy-induced oral mucositis in patients with locally advanced head and neck tum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients [Phase 3]
Phase 3 trial ROMAN assessing GC4419 for radiation-induced oral mucositis in head and neck cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: NR in Chemo-induced Peripheral Neuropathy [Phase 2]
Phase 2 trial update for NR in chemo-induced peripheral neuropathy shows termination with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy [Phase 2]
Phase 2 trial updating nanoliposomal irinotecan for head and neck cancer after platinum-based therapy or chemoradiotherapy has been complete…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating a sequence of chemotherapy followed by surgery, chemotherapy, and radiation therapy for locally advanced h…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: The Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating curcumin for treating cancer anorexia-cachexia syndrome in patients with stage III-IV head and neck cancer…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Individualization of Nutritive Sensory Support Of Radiation Therapy [Phase 4]
A Phase 4 trial update on individualized nutritive sensory support during radiation therapy, studying complications in head and neck cancer …
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer [Phase 1, Phase 2]
A Phase 1/2 study of ADXS11-001 or MEDI4736 alone or in combination for cervical cancer or HPV-associated head and neck cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer [Phase 1, Phase 2]
Clinical trial evaluating concurrent radiation therapy, cisplatin, and BMX-001 in locally advanced head and neck cancer has completed (Phase…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors [Phase 2]
Phase 2 trial evaluating radiotherapy combined with a PD-1 inhibitor and GM-CSF for advanced recurrent metastatic head and neck tumors; curr…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Immunological Variables Associated to ICI Toxicity in Cancer Patients [Phase 2]
A Phase 2 clinical trial investigating immunological variables associated with immune checkpoint inhibitor toxicity in cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer [Phase 2]
Phase 2 clinical trial update evaluating nimotuzumab with cisplatin/radiotherapy in locally advanced head and neck squamous cell cancer has …
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6 [Phase 2]
Phase 2 trial evaluating ABEMACICLIB monotherapy in patients with locally advanced or metastatic head and neck cancer after platinum and cet…
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Clinical trials exploring Boron Neutron Capture Therapy (BNCT) for locally recurrent head and neck cancer have completed Phase 1 and Phase 2…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors [Phase 2]
Phase 2 basket study evaluating simlukafusp alfa in combination therapy for advanced/metastatic solid tumors; study terminated with posted r…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: The HEART Study (Healthy Eating and Recovery Together) [NA]
The HEART Study (Healthy Eating and Recovery Together) completed enrollment with results posted; focuses on head and neck cancer survivorshi…
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery [Phase 3]
Phase 3 trial update on using fluorescence for sentinel lymph node identification in cancer surgery; completed study.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients [Phase 1, Phase 2]
A clinical trial evaluating a Chinese medicine oral rinse for radiation-induced oral mucositis in head and neck cancer patients across Phase…
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36) [Phase 2, Phase 3]
A phase 2/3 trial evaluating bempeg with pembrolizumab versus pembrolizumab alone in metastatic or recurrent head and neck cancer was termin…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating skin rash management before chemotherapy in colorectal and head and neck cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck [Phase 2]
A randomized Phase II trial evaluating optimization of immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck…